Noteworthy, the ILA/IPA ratio reverted to normalcy post-treatment with metformin, suggesting the potential of ILA/IPA as a diagnostic marker or therapeutic target for T2DM. Here, TNFRSF9 is linked to type 2 diabetes mellitus.